Medicare billing address
CMS Medicare provider billing file
1000 Floral Vale BlvdSuite 125
Yardley, PA 19067
CMS public data · NPI 1306892401
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Peter Serpico, D.O.
Specialty
Credential
D.O.
NPI
1306892401
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Peter Serpico, D.O. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
1000 Floral Vale BlvdCMS Doctors & Clinicians file
1000 Floral Vale BlvdCMS Doctors & Clinicians file
2630 Holme AveCMS Doctors & Clinicians file
515 Pennsylvania AveIn the 2024 CMS provider billing file, this NPI had 1,139 Medicare beneficiaries and 9,078 total services. The average beneficiary age was 75, and the average HCC risk score was 1.7.
Total Medicare allowed amount
$486,497.00
Total Medicare payment amount
$374,358.35
Medicare beneficiaries
1,139
Total services
9,078
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Ischemic heart disease
52%
CMS beneficiary-panel share
COPD
51%
CMS beneficiary-panel share
Diabetes
38%
CMS beneficiary-panel share
Anxiety
33%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 1,180 | $130.72 |
| Test to measure expiratory airflow and volume | 267 | $27.92 |
| Test to determine lung volumes using sensors | 249 | $57.21 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 240 | $78.81 |
| Test to examine how well the lungs exchange gases | 226 | $57.63 |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 158 | $169.54 |
| Test for exercise-induced lung stress | 145 | $34.54 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 130 | $132.11 |
| Injection of drug or substance under skin or into muscle | 100 | $14.68 |
| Administration and interpretation of patient-focused health risk assessment | 93 | $3.06 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1306892401. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Albuterol Sulfate Hfa | Albuterol Sulfate | 639 | 790 | $20,885.67 |
| 2 | Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 608 | 891 | $549,458.76 |
| 3 | Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 408 | 559 | $250,525.84 |
| 4 | Prednisone | Prednisone | 255 | 293.1 | $1,032.99 |
| 5 | Montelukast Sodium | Montelukast Sodium | 240 | 544 | $2,737.84 |
| 6 | Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 166 | 290 | $35,034.19 |
| 7 | Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 146 | 180 | $110,214.88 |
| 8 | Breo Ellipta | Fluticasone/Vilanterol | 137 | 213 | $81,831.60 |
| 9 | Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 135 | 204.8 | $93,095.61 |
| 10 | Symbicort | Budesonide/Formoterol Fumarate | 121 | 197 | $39,911.39 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Philadelphia College Of Osteopathic Medicine
Graduation year
1986
Group/practice field
Temple Physicians Inc
Telehealth reported
Yes
Secondary specialty fields reported by CMS: Internal Medicine.
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.